Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2011
11/01/2011CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011CA2409741C Tnf-.alpha. production inhibitors
10/2011
10/27/2011WO2011133875A2 Metalloenzyme inhibitor compounds
10/27/2011WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011WO2011133728A2 Anti-viral compounds
10/27/2011WO2011133183A1 Phase separation sprayed scaffold
10/27/2011WO2011132683A1 Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same
10/27/2011WO2011131748A2 Novel inhibitors
10/27/2011WO2011131741A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
10/27/2011WO2011130918A1 Process for synthesizing imatinib
10/27/2011WO2010078421A8 Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
10/27/2011US20110263861 Quinoline compound
10/27/2011US20110263650 Tubulysin D Analogues
10/27/2011US20110263649 Crystalline form of lenalidomide and a process for its preparation
10/27/2011US20110263648 Bridged tetrahydronaphthalene derivatives
10/27/2011US20110263643 2,3-Disubstituted Piperidine Orexin Receptor Antagonists
10/27/2011US20110263628 N-hydroxyamide derivatives and use thereof
10/27/2011US20110263625 Hiv replication inhibiting pyrimidines
10/27/2011US20110263624 Bicyclic heterocycle derivatives and methods of use thereof
10/27/2011US20110263622 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
10/27/2011US20110263620 Quinoline compounds and their use for treating viral infection
10/27/2011US20110263615 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/27/2011US20110263614 Novel compounds
10/27/2011US20110263612 Compounds that modulate intracellular calcium
10/27/2011US20110263610 Compounds and compositions as itpkb inhibitors
10/27/2011US20110263604 Oxidase inhibitors and their use
10/27/2011US20110263602 Tetrasubstituted pyridazine hedgehog pathway antagonists
10/27/2011US20110263599 7-nonsubstituted indole mcl-1 inhibitors
10/27/2011US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011US20110263570 Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
10/27/2011US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011US20110263566 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same
10/27/2011US20110263565 Compounds
10/27/2011US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011US20110263560 Organic Compounds
10/27/2011US20110263559 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011US20110263558 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
10/27/2011US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011US20110263548 Pyridone and pyridazone analogues as gpr119 modulators
10/27/2011US20110263532 Halofuginone analogs for inhibition of trna synthetases and uses thereof
10/27/2011US20110263530 Aurora Kinase Modulators and Method of Use
10/27/2011US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011US20110263515 Capture agents and related compositions, methods and systems
10/27/2011US20110263431 Pyrrole derivatives for use as plant growth regulators
10/27/2011US20110263428 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
10/27/2011US20110262388 Novel inhibitors
10/27/2011US20110260153 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the same
10/27/2011CA2796637A1 Certain amino-pyrimidines, compositions thereof, and methods for their use
10/27/2011CA2792950A1 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
10/26/2011EP2380888A1 Compound having triazole ring structure with pyridyl group attached thereto, and organic electroluminescent element
10/26/2011EP2380887A1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
10/26/2011EP2380881A1 Novel bicyclic heterocyclic compound
10/26/2011EP2380878A1 Cyclic compound having hetero atom
10/26/2011EP2380631A1 Heteroaryl derivatives as DGAT1 inhibitors
10/26/2011EP2379544A1 Isoxazolines derivatives and their use as pesticide
10/26/2011EP2379531A1 Processes for the manufacture of 3-{4-methyl-5- [ (ir) -1- (2- (3-methylphenyl) -2h-tetrazol-5-yl) -ethoxy]-4h- [1,2, 4]triazol-3-yl} -pyridine, 4-methyl-3-methylthio-5- (3- pyridyl)-l,2,4-triazole, and (ir) -1- [2- (3-methylphenyl) -2h- tetrazol-5-yl]ethanol
10/26/2011EP2379530A1 Pyrimidine indole derivatives for treating cancer
10/26/2011EP2379529A1 Novel compounds
10/26/2011EP2379528A1 Protein kinase inhibitors
10/26/2011EP2379527A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
10/26/2011EP2379526A2 Tetrazole substituted anthranilic acid amides as pesticides
10/26/2011EP2379525A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
10/26/2011EP2379524A1 Serotonin 5-ht2b receptor inhibitors
10/26/2011EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011EP2379522A1 Crystalline form of an organic compound
10/26/2011EP2379515A2 Benzoxazole-based fluorescent metal ion indicators
10/26/2011EP2379506A1 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
10/26/2011EP2379501A1 Method for preparing activated esters
10/26/2011EP2379075A1 Triazole derivatives for treatment of alzheimer's disease
10/26/2011EP2238110B1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
10/26/2011EP2181985B1 Antiviral Agent
10/26/2011EP2176250B1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
10/26/2011EP2066636B1 5-phenyl-nicotinamide derivatives
10/26/2011EP2057141B1 Pyrimidone compounds as gsk-3 inhibitors
10/26/2011EP2037739B1 Benzyl-substituted quinolone m1 receptor positive allosteric modulators
10/26/2011EP2029573B1 Dibenzorylenetetracarboximides as infrared absorbers
10/26/2011EP2001848B1 Piperidines and related compounds for the treatment of dementia
10/26/2011EP1916245B1 Indole derivative having pgd2 receptor antagonist activity
10/26/2011EP1846394B1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/26/2011EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011CN1980934B Novel indole derivatives as selective androgen receptor modulators (sarms)
10/26/2011CN102227421A Anti-proliferation compounds
10/26/2011CN102227420A Quinazolinone, quinolone and related analogs as sirtuin modulators
10/26/2011CN102227411A Antibacterial compounds
10/26/2011CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011CN102227407A Hepatitis c virus inhibitors
10/26/2011CN102225933A 2,6-dimethyl-3,5-bis[3-(5- trifluoromethyl)-1H- pyrazole] pyridine and synthesis method thereof
10/26/2011CN102225932A (Z) type divalent nitenpyram derivatives as well as preparation method and application thereof
10/26/2011CN102225931A Amino acid ester-containing bivalent cis-neonicotinoid compound and its preparation method and application
10/26/2011CN102225930A Method of treatment of age-related macular degeneration(AMD)
10/26/2011CN102225929A Compound of stable Fasudil hydrochloride hydrate
10/26/2011CN102225928A Cis-nitenpyram compound containing tetrahydropyridone ring, its preparation method and application
10/26/2011CN102225927A Amide fragment-containing (Z)-type nitenpyram compound and preparation method and application thereof
10/26/2011CN102225926A Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/26/2011CN102225925A Compound with activity for resisting chronic cell leukemia and preparation method thereof
10/26/2011CN101070304B Quinoline derivatives and their use as mycrobacterial inhibitors
10/25/2011US8044209 Pyrrolydine derivatives as IAP inhibitors
10/25/2011US8044207 Pyridinoylpiperidines as 5-HT1F agonists
10/25/2011US8044202 Azaspiro derivatives
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 1080